At this time, posts about Daewon Pharmaceutical are rapidly increasing on portals and stock communities. Today, foreigners have net sold 24,000 shares of Daewon Pharmaceutical, and institutions have net sold 233,000 shares, according to provisional data. Daewon Pharmaceutical is known as a specialized pharmaceutical manufacturer focusing on therapeutic drugs.

As of 11:30 AM on the 17th, Daewon Pharmaceutical's stock price is 19,850 KRW, up 13.11% from the previous day, with a trading volume of 10,628,338 shares, which is 394.37% of the 5-day average trading volume. On June 15, Daewon Pharmaceutical was a market topic with the headline "ESG Excellent Effect?... Emerging as a Representative Stock in the Pharmaceutical Sector."

In addition to Daewon Pharmaceutical, posts about Ilyang Pharmaceutical Preferred (007575), Hanwha (000880), and Doosan Bobcat (241560) are also rapidly increasing among investors.

※Source: AI Investment Assistant AI Rassi

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing